Centinel Spine Files for US IPO
Medical device maker Centinel Spine filed for a US initial public offering after reporting a significant rise in revenue and profitability for the first half of the year. The Pennsylvania-based company plans to list its shares on the New York Stock Exchange.
Insights:
Centinel Spine revealed a 42% rise in first-half revenue in its United States IPO filing on Wednesday morning. The filing arrives during an uncertain period for the fall public offering market. Rising bond yields have dampened investor appetite across the sector.
